Healthcare -
Biotechnology - NASDAQ - US
$ 1.82
-1.09 %
$ 382 M
Market Cap
-1.17
P/E
ALLO - TAX PROVISION
Tax Provision ALLO - Allogene Therapeutics, Inc.
0
LAST VALUE
41.42%
2 YEAR CAGR
14.87%
5 YEAR CAGR
0.00%
10 YEAR CAGR